Randomized Controlled Trials

Created:   1/31/2012
Contains:  20 items
Transplantation is pleased to present this collection of high quality randomised controlled trials and studies in kidney, liver, thoracic and stem cell transplantation. We hope you find this collection helpful and stimulating, and encourage you to provide us with your own suggestions of excellent articles for this and other future collections.

Randomized Trial of Dual Antibody Induction Therapy With Steroid Avoidance in Renal Transplantation

Ciancio, Gaetano; Gaynor, Jeffrey J.; Sageshima, Junichiro; More

Transplantation. 92(12):1348-1357, December 27, 2011.

Randomized Trial of Mycophenolate Mofetil Versus Enteric-Coated Mycophenolate Sodium in Primary Renal Transplantation With Tacrolimus and Steroid Avoidance: Four-Year Analysis

Ciancio, Gaetano; Gaynor, Jeffrey J.; Zarak, Alberto; More

Transplantation. 91(11):1198-1205, June 15, 2011.

Kidney Transplantation With Minimized Maintenance: Alemtuzumab Induction With Tacrolimus Monotherapy—An Open Label, Randomized Trial

Chan, Kakit; Taube, David; Roufosse, Candice; More

Transplantation. 92(7):774-780, October 15, 2011.

Conversion of Long-Term Kidney Transplant Recipients From Calcineurin Inhibitor Therapy to Everolimus: A Randomized, Multicenter, 24-Month Study

Holdaas, Hallvard; Rostaing, Lionel; Serón, Daniel; More

Transplantation. 92(4):410-418, August 27, 2011.

Renal Function, Efficacy, and Safety of Sirolimus and Mycophenolate Mofetil After Short-Term Calcineurin Inhibitor-Based Quadruple Therapy in De Novo Renal Transplant Patients:...

Guba, Markus; Pratschke, Johann; Hugo, Christian; More

Transplantation. 90(2):175-183, July 27, 2010.

Randomized Controlled Trial: Lisinopril Reduces Proteinuria, Ammonia, and Renal Polypeptide Tubular Catabolism in Patients With Chronic Allograft Nephropathy

Amara, Alieu B.; Sharma, Asheesh; Alexander, John L.; More

Transplantation. 89(1):104-114, January 15, 2010.

Effect of Everolimus Introduction on Cardiac Allograft Vasculopathy—Results of a Randomized, Multicenter Trial

Arora, Satish; Ueland, Thor; Wennerblom, Bertil; More

Transplantation. 92(2):235-243, July 27, 2011.

Two-Year Outcomes in Thoracic Transplant Recipients After Conversion to Everolimus With Reduced Calcineurin Inhibitor Within a Multicenter, Open-Label, Randomized Trial

Gullestad, Lars; Mortensen, Svend-Aage; Eiskjær, Hans; More

Transplantation. 90(12):1581-1589, December 27, 2010.

Everolimus With Reduced Calcineurin Inhibitor in Thoracic Transplant Recipients With Renal Dysfunction: A Multicenter, Randomized Trial

Gullestad, Lars; Iversen, Martin; Mortensen, Svend-Aage; More

Transplantation. 89(7):864-872, April 15, 2010.

Glutamine-Enriched Nutrition Does Not Reduce Mucosal Morbidity or Complications After Stem-Cell Transplantation for Childhood Malignancies: A Prospective Randomized Study

Uderzo, Cornelio; Rebora, Paola; Marrocco, Emanuela; More

Transplantation. 91(12):1321-1325, June 27, 2011.